Xconomy National

Archives

by in
Entry Author Date Location
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups Luke Timmerman 12/22/11 Seattle
Arteaus, With $18M From Atlas and OrbiMed, Forges Ahead on Migraine-Prevention Drug Arlene Weintraub 10/19/11 Boston
Zogenix Strategy Unfolds as it Unveils Plans for Next Drug-and-Device Combo Bruce V. Bigelow 07/19/11 San Diego
Dendreon Moves Across Town, SeaGen Files FDA App, Alder Takes Road Less Traveled, & More Seattle Life Sciences News Luke Timmerman 03/03/11 Seattle
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol Luke Timmerman 03/02/11 Seattle
Saagara Planning New Health Apps, Getting Advice from Ted Dacko, Former HealthMedia Chief Ryan McBride 12/14/10 Detroit
Stopping Migraines Before They Hurt: NeurAxon Pursues New Pain Drug Luke Timmerman 02/02/09 Boston
Torrey Pines Therapeutics Permitted to Begin Phase III Trial of Migraine Drug Luke Timmerman 10/01/08 San Diego
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.